You are here

Press Releases

March 17, 2021
WASHINGTON, D.C. – In response to the Biden administration’s announcement today of its plan to expand COVID-19 testing in our nation’s K-8 schools, AdvaMed — the world’s largest trade association representing medical technology companies — released... Read More
February 22, 2021
Outgoing Chair Doug Bryant praised for leadership through pandemic WASHINGTON, D.C. – AdvaMedDx, the division within AdvaMed representing manufacturers of in vitro diagnostic tests, foundational to the delivery of quality health care, announced that... Read More
October 20, 2020
WASHINGTON, D.C. –New data from AdvaMed’s COVID-19 Diagnostic Supply Registry reveals that total U.S. shipments of COVID-19 molecular diagnostic tests have reached 200 million. A breakdown of the data shows that innovative diagnostics companies are... Read More
October 13, 2020
WASHINGTON, D.C. – New data from AdvaMed’s COVID-19 Diagnostic Supply Registry reveals that total U.S. shipments of COVID-19 molecular diagnostic tests have reached over 190 million. A breakdown of the data shows that innovative diagnostics... Read More
October 6, 2020
WASHINGTON, D.C. – New data from AdvaMed’s COVID-19 Diagnostic Supply Registry reveals that total U.S. shipments of COVID-19 molecular diagnostic tests have reached over 180 million. A breakdown of the data shows that innovative diagnostics... Read More
October 3, 2020
“Game-changing” testing innovation from Quidel will save lives heading into flu season WASHINGTON, D.C. – AdvaMed released the following statements on the announcement last night that Quidel Corporation, a member company of AdvaMed and AdvaMedDx,... Read More
September 23, 2020
WASHINGTON, D.C. – New data from AdvaMed’s COVID-19 Diagnostic Supply Registry reveals that total U.S. shipments of COVID-19 molecular diagnostic tests have reached 160 million. A breakdown of the data shows that innovative diagnostics companies are... Read More
September 17, 2020
100-million-plus antigen tests to be shipped by end of fall WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today announced that total U.S. shipments of COVID-19 molecular diagnostic tests have reached more than 150 million... Read More
August 20, 2020
WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker released the following statement: “AdvaMed fully supports policies that foster innovation and regulatory flexibility to speed quality tests to patients. This principle is core to the... Read More
August 4, 2020
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today announced that total U.S. shipments of COVID-19 molecular diagnostic tests reached approximately 100 million, as of July 25, based on the latest data from the association... Read More

Pages